The Markets

A2 shares plunge over FDA formula deferral

Wednesday 10th of August 2022

The milk company told the NZX that the US Food and Drug Administration (FDA) is deferring further consideration of the company’s request for enforcement discretion to import infant milk formula products into the US.

The shares dropped 11% to $5.01 when New Zealand’s market opened but made up for a bit of lost ground throughout the day, ending it down 7.5% to $5.21.

T...

Want to read the full article?
Click the button below to subscribe and will have unlimited access to full article and all other articles on the site.